Molecular marker analyses demonstrated a significant decrease in the expression of the hypertrophic and cardiomyopathy marker genes Nppa, Nppb, and Myh7/Myh6 in AAV-LncHrt-treated hearts (Fig. 3n). Here, MYH6 is linked to cardiomyopathy.